You are in : Home » Results & submissions » Select UOA » 4 - Psychology, Psychiatry and Neuroscience » View submission: University of Cambridge » Outputs » Detail

Output details

4 - Psychology, Psychiatry and Neuroscience

University of Cambridge

Return to search Previous output Next output

Output 23 of 299 in the submission

Article title

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Type

D - Journal article

DOI

10.1016/S0140-6736(12)61769-3

Title of journal

The Lancet

Article number

Volume number

380

Issue number

9856

First page of article

1819

ISSN of journal

01406736

Year of publication

2012

URL

http://www.ncbi.nlm.nih.gov/pubmed/23122652

Number of additional authors

Additional information

Interdisciplinary

Cross-referral requested

Research group

None

Citation count

Proposed double-weighted

Double-weighted statement

Reserve for a double-weighted output

Non-English

English abstract